About Genpathway

Genpathway is an early-stage pharmacogenomics company that provides specialized drug and biomarker discovery services and develops novel diagnostic biomarkers that predict drug responses, enabling personalized treatments. The company applies its proprietary chromatin and methylated DNA immunoprecipitation sequencing (ChIP-Seq) technology to understand gene regulation and genetic pathways by studying transcription factor binding, gene transcription, and epigenetic events such as DNA methylation and histone modifications. Based on the information gained from its platform technology, Genpathway intends to develop and commercialize a broad portfolio of clinically validated molecular diagnostic products and services that will enable the accurate selection of specific drugs to efficaciously treat individuals with cancer, immune disorders, and other serious diseases.